Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 68180-249

9 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 68180-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (9668ab88 Cfbd 401c A428 777988f20f27 01)

Figure 1 (9668ab88 Cfbd 401c A428 777988f20f27 01)
Chemical structure of memantine hydrochloride showing the molecular arrangement of the amine, hydrochloride, and methyl groups attached to the adamantane core.*
FDA Label Image

Figure 2 (9668ab88 Cfbd 401c A428 777988f20f27 02)

Figure 2 (9668ab88 Cfbd 401c A428 777988f20f27 02)
A line graph showing mean change from baseline in SIB Score over 24 weeks of treatment comparing Memantine HCl Extended-Release 28 mg with placebo, both alongside AChEI. The graph includes error bars representing SEM and illustrates clinical improvement above zero and clinical decline below, with data points tracked at multiple weeks.*
FDA Label Image

Figure 3 (9668ab88 Cfbd 401c A428 777988f20f27 03)

Figure 3 (9668ab88 Cfbd 401c A428 777988f20f27 03)
A cumulative percentage curve graph comparing memantine hydrochloride extended-release 28 mg with placebo on SIB change from baseline in patients. The x-axis represents SIB change from baseline, and the y-axis shows the cumulative percentage of patients. Two lines, one with filled circles for memantine and one with open circles for placebo, illustrate patient outcome distributions.*
FDA Label Image

Figure 4 (9668ab88 Cfbd 401c A428 777988f20f27 04)

Figure 4 (9668ab88 Cfbd 401c A428 777988f20f27 04)
A line graph showing the mean CBIC-Plus scores over 24 weeks of treatment comparing Memantine HCl Extended-Release 28 mg/AChEI and Placebo/AChEI groups. The graph includes error bars (± SEM) and indicates clinical improvement and decline thresholds.*
FDA Label Image

Figure 5 (9668ab88 Cfbd 401c A428 777988f20f27 05)

Figure 5 (9668ab88 Cfbd 401c A428 777988f20f27 05)
A bar chart comparing the percentage of patients across different Clinical Global Impression of Change (CIBIC Plus) rating categories between those treated with Memantine Hydrochloride Extended-Release 28 mg combined with AChEI and placebo with AChEI. Categories include marked, moderate, minimal improvement, no change, minimal, moderate, and marked worsening, with corresponding patient percentages displayed on the vertical axis.*
FDA Label Image

7mg (30s Bottle)

7mg (30s Bottle)
Label for Memantine Hydrochloride Extended-release Capsules 7 mg, oral dosage form. The label indicates a package of 30 capsules, labeled for prescription use only. Manufactured for Lupin Pharmaceuticals, Inc., with Lupin Limited in India as the manufacturer. Includes storage and dispensing instructions on this white and green label.*
FDA Label Image

14 mg- 30s Bottle (9668ab88 Cfbd 401c A428 777988f20f27 07)

14 mg- 30s Bottle (9668ab88 Cfbd 401c A428 777988f20f27 07)
Label for Memantine Hydrochloride Extended-release Capsules, 14 mg strength. The label states the product is a once-daily dosage, with 30 capsules per bottle, labeled for prescription use only. Manufactured for Lupin Pharmaceuticals, Inc. and Lupin Limited (India). Storage conditions and dosage instructions are noted with a barcode included.*
FDA Label Image

21 mg-30s Bottle (9668ab88 Cfbd 401c A428 777988f20f27 08)

21 mg-30s Bottle (9668ab88 Cfbd 401c A428 777988f20f27 08)
Label for Memantine Hydrochloride Extended-release Capsules 21 mg by Lupin Pharmaceuticals, Inc. The label states the product is for oral use, contains 30 capsules, and is prescription only. It includes storage information, manufacturer details, and a barcode with NDC 68180-248-06.*
FDA Label Image

28 mg (30s Bottle)

28 mg (30s Bottle)
Label for Memantine Hydrochloride Extended-release Capsules 28 mg, featuring the NDC 68180-249-06. The label indicates a once-daily oral capsule dosage form, with a package containing 30 capsules. Manufactured by Lupin Pharmaceuticals, Inc., Baltimore, Maryland, and Lupin Limited, India. Storage and dispensing instructions are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.